SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

25 Oct 2024 Evaluate
Net sales declined -12.21%  to  Rs. 347.16 million from Rs. 395.44 millions.The Net proft of the company remain more or less same to Rs. 105.67  millions from Rs. 125.43 millions ,decline by -15.75%.The Operating Profit of the company witnessed a decrease to 157.10 millions from 178.21 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 347.16 395.44 -12.21 735.43 891.32 -17.49 1698.22 1483.85 14.45
Other Income 3.19 10.97 -70.92 8.43 21.72 -61.19 43.66 65.88 -33.73
PBIDT 157.10 178.21 -11.85 347.85 424.02 -17.96 831.00 802.17 3.59
Interest 0.82 0.51 60.78 1.48 0.76 94.74 2.29 1.76 30.11
PBDT 156.28 177.70 -12.05 346.37 423.26 -18.17 828.71 800.41 3.54
Depreciation 14.36 8.84 62.44 25.84 16.33 58.24 35.36 25.76 37.27
PBT 141.92 168.86 -15.95 320.53 406.93 -21.23 793.35 774.65 2.41
TAX 36.25 43.43 -16.53 82.49 104.29 -20.90 201.71 194.96 3.46
Deferred Tax 0.08 1.11 -92.79 0.61 2.07 -70.53 3.75 2.55 47.06
PAT 105.67 125.43 -15.75 238.04 302.64 -21.35 591.64 579.69 2.06
Equity 108.97 72.64 50.01 108.97 72.64 50.01 72.64 72.64 0.00
PBIDTM(%) 45.25 45.07 0.41 47.30 47.57 -0.57 48.93 54.06 -9.48

Guj. Themis Biosyn Share Price

333.60 -0.55 (-0.16%)
21-Apr-2026 10:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.70
Dr. Reddys Lab 1222.75
Cipla 1230.90
Zydus Lifesciences 931.45
Lupin 2326.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×